Terminalia Arjuna
15 benefits mapped to clinical evidence across supplements.
Dose per serving from products
33 products in our catalogue print how much Terminalia Arjuna a serving holds.
Most common: 50 mg to 100 mg, 21% of 33 products.
| Dose per serving | Products |
|---|---|
| 10 mg to 25 mg | 6 |
| 25 mg to 50 mg | 5 |
| 50 mg to 100 mg | 7 |
| 100 mg to 250 mg | 5 |
| 250 mg to 500 mg | 4 |
| 500 mg to 1 g | 3 |
| 1 g to 2.5 g | 1 |
| over 2.5 g | 2 |
Dose per serving from research
9 study groups in 8 studies say how much Terminalia Arjuna participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 g to 2.5 g, 56% of 9 study groups.
| Daily dose | Study groups |
|---|---|
| 250 mg to 500 mg | 2 |
| 500 mg to 1 g | 1 |
| 1 g to 2.5 g | 5 |
| 2.5 g to 5 g | 0 |
| 5 g to 10 g | 1 |
Benefit Evidence
Research sources
Heart health (9)
- Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial
PubMed ID: 26988798
12âweek CHF addâon trial preserved antioxidant enzymes and improved functional capacity in subgroups, though primary LVEF endpoint was negative.
- Effect of Arjun ChÄl on cardiovascular risk factors - a randomized controlled clinical trial
PubMed ID: 33977687
Direct small RCT of T. arjuna showed reductions in lipids, blood pressure and BMI â direct clinical evidence for cardiovascular support (limited sample/duration).
- Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence
PubMed ID: 25827448
Addâon RCT in CAD showed favourable lipid and immunoâinflammatory changes (supports cardiac risk modification).
- Role of Terminalia arjuna in ischaemic mitral regurgitation
PubMed ID: 15837100
PostâMI trial reported less ischemic mitral regurgitation and fewer angina episodes with T. arjuna (direct cardiac outcome signals).
- Terminalia arjuna reverses impaired endothelial function in chronic smokers
PubMed ID: 15377133
Twoâweek RCT demonstrated improved endothelial function in smokers with T. arjuna, supporting vascular/cardiac benefit.
- Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial
PubMed ID: 11225136
Oneâmonth RCT lowered total/LDL cholesterol and lipid peroxides in coronary patients â supports cardiac risk factors.
- Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate
PubMed ID: 12086380
T. arjuna improved angina symptoms and exercise tolerance comparable to nitrate therapy (direct RCT evidence for symptomatic cardiac benefit).
- Effect of E-OJ-01 on Cardiac Conditioning in Young Exercising Adults: A Randomized Controlled Trial
PubMed ID: 27930383
EâOJâ01 (T. arjuna extract) improved LVEF and cardiac performance markers in exercising adults (direct small RCT).
- Effect of an aqueous extract of Terminalia chebula on endothelial dysfunction, systemic inflammation, and lipid profile in type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical study
PubMed ID: 32618037
T. chebula improved endothelial function and NO in T2DM patients â supports vascular/heart function but is a different Terminalia species.
Metabolism (4)
- Effect of an aqueous extract of Terminalia chebula on endothelial dysfunction, systemic inflammation, and lipid profile in type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical study
PubMed ID: 32618037
T. chebula improved endothelial function and lipid markers in T2DM patients â relevant to metabolic balance though species differs.
- Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial
PubMed ID: 11225136
Oneâmonth RCT reduced total/LDL cholesterol and lipid peroxides, indicating metabolic (lipid) improvements.
- Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence
PubMed ID: 25827448
Addâon RCT in CAD lowered triglycerides/VLDL and altered immunoâmetabolic markers (direct metabolic effects).
- Effect of Arjun ChÄl on cardiovascular risk factors - a randomized controlled clinical trial
PubMed ID: 33977687
T. arjuna trial demonstrated reductions in lipids, BP and BMI â supports metabolic benefits in a small RCT.
Antioxidant (4)
- Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial
PubMed ID: 26988798
CHF trial preserved/increased RBC catalase/SOD/GSH activity in treated patients (supports antioxidant effects).
- Effect of an aqueous extract of Terminalia chebula on endothelial dysfunction, systemic inflammation, and lipid profile in type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical study
PubMed ID: 32618037
T. chebula improved oxidative/vascular biomarkers (NO, reflection index) in diabetics, supporting antioxidant/vascular protection though species differs.
- Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial
PubMed ID: 11225136
Oneâmonth RCT showed substantial reduction in lipid peroxides (TBARS) with T. arjuna (direct antioxidant biomarker improvement).
- Terminalia arjuna reverses impaired endothelial function in chronic smokers
PubMed ID: 15377133
Improved endothelial function in smokers likely reflects antioxidant/vascular protective actions of T. arjuna.
Blood circulation (4)
- Effect of an aqueous extract of Terminalia chebula on endothelial dysfunction, systemic inflammation, and lipid profile in type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical study
PubMed ID: 32618037
T. chebula improved reflection index and nitric oxide vs placebo in T2DM patients â direct evidence of improved vascular function (species differs).
- Terminalia arjuna reverses impaired endothelial function in chronic smokers
PubMed ID: 15377133
Twoâweek crossover RCT: T. arjuna markedly improved flowâmediated (endotheliumâdependent) vasodilation in smokers (strong vascular evidence).
- Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate
PubMed ID: 12086380
Reduced angina and improved exercise tolerance imply improved myocardial perfusion/functional circulation.
- Effect of E-OJ-01 on Cardiac Conditioning in Young Exercising Adults: A Randomized Controlled Trial
PubMed ID: 27930383
Cardiac performance indexes and LVEF improvements in exercising adults suggest better cardiac/vascular performance.
Cholesterol (3)
- Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial
PubMed ID: 11225136
Randomized placeboâcontrolled trial: T. arjuna bark powder lowered total cholesterol (~â9.7%) and LDL (~â15.8%) after 1 month (direct evidence).
- Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence
PubMed ID: 25827448
T. arjuna addâon in CAD significantly downâregulated triglycerides/VLDL and improved lipid markers (direct lipid benefit).
- Effect of Arjun ChÄl on cardiovascular risk factors - a randomized controlled clinical trial
PubMed ID: 33977687
Small RCT of T. arjuna reported lipid profile reductions over 8 weeks â direct support for cholesterol balance (limited size/duration).
Joint comfort (3)
- A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia
PubMed ID: 32933504
T. bellerica reduced serum uric acid (24âweek RCT), which is mechanistically relevant to gout/joint comfort; different Terminalia species though.
- Effects of dietary supplementation with a standardized aqueous extract of Terminalia chebula fruit (AyuFlex(ÂŽ)) on joint mobility, comfort, and functional capacity in healthy overweight subjects: a randomized placebo-controlled clinical trial
PubMed ID: 28969626
Standardized T. chebula extract improved knee pain/function in overweight adults â species different from T. arjuna but clinically relevant to joints.
- A Placebo-Controlled Double-Blind Study Demonstrates the Clinical Efficacy of a Novel Herbal Formulation for Relieving Joint Discomfort in Human Subjects with Osteoarthritis of Knee
PubMed ID: 29708818
LI73014F2 (contains T. chebula) reduced pain and improved function in knee OA â relevant to joint comfort but not pure T. arjuna.
Vitality (3)
- Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial
PubMed ID: 26988798
CHF addâon trial showed improved functional capacity and some QoL domains in subgroups (modest vitality signal).
- Effect of Arjun ChÄl on cardiovascular risk factors - a randomized controlled clinical trial
PubMed ID: 33977687
T. arjuna trial improved several cardio/metabolic risk markers (BP, lipids, BMI) that can translate to better perceived vitality.
- Effect of E-OJ-01 on Cardiac Conditioning in Young Exercising Adults: A Randomized Controlled Trial
PubMed ID: 27930383
Reduced perceived exercise fatigue and improved cardiac performance in exercising adults could reflect increased vitality.
Immune support (1)
- Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence
PubMed ID: 25827448
T. arjuna RCT in CAD showed reductions in immunoâinflammatory markers (directly relevant).
Inflammation (1)
- Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence
PubMed ID: 25827448
Study reported reductions in immunoâinflammatory markers with T. arjuna in CAD patients (direct antiâinflammatory signal).
Illness recovery (1)
- A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia
PubMed ID: 32933504
T. bellerica improved renal function (creatinine down, eGFR up) over 24 weeks â supports recovery of renal function; species differs.
Blood pressure (1)
- Effect of Arjun ChÄl on cardiovascular risk factors - a randomized controlled clinical trial
PubMed ID: 33977687
Small RCT of T. arjuna showed blood pressure reductions â direct evidence for BPâlowering in short term.
Weight management (1)
- Effect of Arjun ChÄl on cardiovascular risk factors - a randomized controlled clinical trial
PubMed ID: 33977687
T. arjuna powder reduced BMI in patients with cardiovascular risk factors over 8 weeks â direct but small/short trial evidence.
Skin health (1)
- Evaluation of the efficacy of topical Terminalia chebula Retz. with vinegar in the treatment of tinea corporis: a non-inferiority randomized controlled trial
PubMed ID: 37012894
Topical T. chebula was nonâinferior to terbinafine for tinea corporis in a randomized trial â direct clinical skin benefit (different Terminalia species).
Endurance (1)
- Effect of E-OJ-01 on Cardiac Conditioning in Young Exercising Adults: A Randomized Controlled Trial
PubMed ID: 27930383
T. arjuna extract improved exerciseârelated cardiac performance and reduced perceived fatigue in exercising men.
Energy & Fatigue (1)
- Effect of E-OJ-01 on Cardiac Conditioning in Young Exercising Adults: A Randomized Controlled Trial
PubMed ID: 27930383
Study reported lower postâexercise perceived exertion/fatigue with T. arjuna extract (supports perceived energy/endurance).
Similar by evidence
Supplements the same benefits carry qualifying findings for â a fact about the evidence graph, not a recommendation to swap.
Products with Terminalia Arjuna
Search all72 products whose verified label declares Terminalia Arjuna â not every bottle that mentions it in a title.